Alterations of Glt-1 and GLAST expression and activity have been associated with many neurological disorders such as schizophrenia, epilepsy and Alzheimer’s disease (AD) [7,8]. The gene discussed is SLC1A3; the disease is early-onset autosomal dominant Alzheimer disease.